Group Vice President and General Manager, Orphan Business Unit
Mr. Andersen joined Horizon Pharma in September 2014 as group vice president and general manager, orphan business unit. Prior to joining Horizon Pharma, Mr. Andersen most recently served as the vice president of sales and marketing until its acquisition by Horizon Pharma. Prior to joining Vidara, Mr. Andersen led marketing teams at Lundbeck (Ovation) and EKR Therapeutics, where he was responsible for the successful turnaround of Panhematin and the launch of the Cardene IV Ready-to-Use Bag. From 2008-2009, Mr. Andersen led sales training teams through the launch of Sabril. From 2005-2008, Mr. Andersen built numerous sales teams at both PDL BioPharma and ESP Pharma focused on selling acute-care and oncology products through hospital channels. From 1999-2002, Mr. Andersen was a hospital representative at Pharmacia where he won multiple sales awards.
Mr. Andersen holds a BS in biology from the University of Illinois and an MBA from Northwestern University’s Kellogg School of Management.